Global Pharmaceutical & Biotechnology Outlook 2013: India Pharma
Reportstack, provider of premium market research reports announces the addition of Global Pharmaceutical & Biotechnology Outlook 2013: India Pharma market report to its offering
India pharma rode on the wave of bunched up patent expiries in the US with many Para IV launches in 2012. In addition, it also benefited from the continuing high teen growth of Indian pharma market. With patent expiries in the US dwindling from $30b in 2012 to $10b in 2013 (small molecules), Indian generic companies...
View full press release